SOBR vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

SOBR

45.2
AI Score
VS
SOBR Wins

MLAB

35.5
AI Score

Investment Advisor Scores

SOBR

45score
Recommendation
HOLD

MLAB

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric SOBR MLAB Winner
Forward P/E 0 34.4828 Tie
PEG Ratio 0 0 Tie
Revenue Growth -72.1% 1.0% MLAB
Earnings Growth 0.0% -42.4% SOBR
Tradestie Score 45.2/100 35.5/100 SOBR
Profit Margin 0.0% 1.9% MLAB
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY SOBR

Relative Price Performance (Last 90 Days)

SOBR 1M: -63.2% · 3M: -79.1% MLAB 1M: +2.4% · 3M: +30.5%

Current Technical Phase

SOBR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.0%), weak momentum, RSI 25

RSI (14): 24.7 · Price: $0.20

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.3% over 20 days), RSI 61

RSI (14): 60.8 · Price: $133.82

Fundamentals Snapshot

Metric SOBR MLAB
Market Cap — —
Forward P/E 0.0 24.0
Trailing P/E — 154.7
Revenue (TTM) — —
Revenue Growth -0.7% 0.0%
Gross Margin 0.1% 0.6%
Operating Margin -67.5% 0.1%
EPS -5.35 0.84
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, SOBR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.